Mirae Asset Global Investments Co., Ltd. Ionis Pharmaceuticals Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,288 shares of IONS stock, worth $187,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,288

Previous 4,358 21.34%

Holding current value

$187,036

Previous $207,000 1.93%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$40.06 - $51.86 $37,255 - $48,229	930 Added 21.34%	5,288 $211,000
Q2 2024 Jul 30, 2024	SELL	$36.45 - $47.7 $390,853 - $511,487	-10,723 Reduced 71.1%	4,358 $207,000
Q1 2024 May 01, 2024	BUY	$42.03 - $53.55 $633,854 - $807,587	15,081 New	15,081 $653,000
Q3 2023 Oct 26, 2023	BUY	$38.5 - $47.13 $4,966 - $6,079	129 Added 1.08%	12,042 $546,000
Q2 2023 Aug 10, 2023	SELL	$34.73 - $43.33 $127,042 - $158,501	-3,658 Reduced 23.49%	11,913 $488,000
Q1 2023 May 04, 2023	BUY	$33.58 - $41.2 $522,874 - $641,525	15,571 New	15,571 $556,000
Q4 2021 Feb 08, 2022	SELL	$25.61 - $35.1 $169,000 - $231,624	-6,599 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $221,330 - $267,589	6,599 New	6,599 $221,000
Q2 2021 Aug 11, 2021	SELL	$34.54 - $47.25 $268,444 - $367,227	-7,772 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$42.51 - $63.78 $32,817 - $49,238	-772 Reduced 9.04%	7,772 $350,000
Q4 2020 Feb 10, 2021	BUY	$45.3 - $60.27 $14,088 - $18,743	311 Added 3.78%	8,544 $483,000
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $149,847 - $198,796	3,158 Added 62.23%	8,233 $391,000
Q2 2020 Aug 11, 2020	BUY	$46.85 - $61.05 $25,954 - $33,821	554 Added 12.25%	5,075 $299,000
Q1 2020 May 12, 2020	SELL	$41.6 - $63.4 $13,811 - $21,048	-332 Reduced 6.84%	4,521 $214,000
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $13,354 - $16,186	248 Added 5.39%	4,853 $293,000
Q3 2019 Nov 12, 2019	BUY	$59.06 - $72.15 $12,816 - $15,656	217 Added 4.95%	4,605 $276,000
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $8,009 - $11,112	129 Added 3.03%	4,388 $282,000
Q1 2019 May 13, 2019	BUY	$52.92 - $81.17 $225,386 - $345,703	4,259 New	4,259 $346,000

Others Institutions Holding IONS

# of Institutions

404

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Ionis Pharmaceuticals Inc Transaction History